Publication

Article

Oncology Live®
July 2012
Volume 13
Issue 7

Smokers More Likely to Recall Graphic Warning Labels

Author(s):

Smokers are better able to remember the printed health-risk warnings that appear in cigarette advertisements and labels when the messages include images.

Smokers are better able to remember the printed health-risk warnings that appear in cigarette advertisements and labels when the messages include images, according to a study published in the American Journal of Preventive Medicine in July.

A team of investigators from the Perelman School of Medicine at the University of Pennsylvania in Philadelphia launched the study in light of the FDA’s decision to require cigarette packages and advertisements to feature larger health warnings that include graphic images, such as a patient hooked up to medical machines and a man smoking through a hole in his throat.

The changes were scheduled to take effect by September 2012, but are on hold due to litigation filed in November 2011 by four tobacco companies, which argue that the new labels would violate their First Amendment rights, according to lead author Andrew A. Strasser, PhD, and his colleagues.

Conducted between November 2008 and 2009, the study was designed to evaluate differences in the way smokers viewed and recalled text-only cigarette danger warnings as compared with those presented with an image. Eye-tracking techniques were used to determine the viewing patterns of 200 daily smokers who participated in the study, and recall was later assessed.

Correct recall of the warning label occurred among 83% of those who had viewed a graphic message and among 50% of those who had viewed a text-only communication (P = .0001), Strasser et al wrote. Better recall was associated with more immediate viewing of the text and longer viewing of the image, the authors found.

Related Videos
Erminia Massarelli, MD, PhD, MS
Karen L. Reckamp, MD, MS
Jacob Sands, MD, oncology medical director, International Patient Center, Dana-Farber Cancer Institute; assistant professor, Harvard Medical School
Fred R. Hirsch, MD, PhD, executive director, Center for Thoracic Oncology, The Tisch Cancer Institute at Mount Sinai; Joe Lowe and Louis Price Professor of Medicine (Hematology and Medical Oncology), Icahn School of Medicine at Mount Sinai
Julia Rotow, MD, clinical director, Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute; assistant professor, medicine, Harvard Medical School
Joshua K. Sabari, MD, assistant professor, Department of Medicine, New York University Grossman School of Medicine; director, High Reliability Organization Initiatives, Perlmutter Cancer Center
Leah Backhus, MD, MPH, FACS, professor, University Medical Line, Cardiothoracic Surgery, co-director, Thoracic Surgery Clinical Research Program, associate program director, Thoracic Track, CT Surgery Residency Training Program, Thelma and Henry Doelger Professor of Cardiovascular Surgery, Stanford Medicine; chief, Thoracic Surgery, VA Palo Alto
Roy S. Herbst, MD, PhD, Ensign Professor of Medicine (Medical Oncology), professor, pharmacology, deputy director, Yale Cancer Center; chief, Medical Oncology, director, Center for Thoracic Cancers, Yale Cancer Center and Smilow Cancer Hospital; assistant dean, Translational Research, Yale School of Medicine
A panel of 4 experts on lung cancer
A panel of 4 experts on lung cancer